Evidence map›Paper›PMID 25733504›Full record

Trial reportAntimicrobial agents and chemotherapy2015

Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares.

Michele J Anderson, Maren L David, Matt Scholz, Sally J Bull, Dan Morse, Michelle Hulse-Stevens, Marnie L Peterson

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Intranasal Testing and Treatment forJournal of the Pediatric Orthopaedic Society of North America · 2025
    Article
  5. Acta medica Philippina · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. The antimicrobial potential of cannabidiol.Communications biology · 2021
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Preoperative decolonization to reduce infections in urgent lower extremity repairs.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2018
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michele J AndersonDepartment of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Maren L David3M Infection Prevention Division, 3M Company, St. Paul, Minnesota, USA.
Matt Scholz3M Infection Prevention Division, 3M Company, St. Paul, Minnesota, USA.
Sally J Bull3M Infection Prevention Division, 3M Company, St. Paul, Minnesota, USA.
Dan Morse3M Infection Prevention Division, 3M Company, St. Paul, Minnesota, USA.
Michelle Hulse-Stevens3M Infection Prevention Division, 3M Company, St. Paul, Minnesota, USA.
Marnie L PetersonDepartment of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA peter377@umn.edu.
3M (United States) · USUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mupirocin decolonization of nasal Staphylococcus aureus prior to surgery decreases surgical-site infections; however, treatment requires 5 days, compliance is low, and resistance occurs. In 2010, 3M Company introduced povidone-iodine (PVP-I)-based skin and nasal antiseptic (Skin and Nasal Prep [SNP]). SNP has rapid, broad-spectrum antimicrobial activity. We tested SNP's efficacy using full-thickness tissue (porcine mucosal [PM] and human skin) explant models and human subjects. Prior to or following infection with methicillin-resistant Staphylococcus aureus (MRSA) (mupirocin sensitive and resistant), explants were treated with Betadine ophthalmic preparation (Bet), SNP, or mupirocin (Bactroban nasal ointment [BN]) or left untreated. One hour posttreatment, explants were washed with phosphate-buffered saline (PBS) plus 2% mucin. One, 6, or 12 h later, bacteria were recovered and enumerated. Alternatively, following baseline sampling, human subjects applied two consecutive applications of SNP or saline to their anterior nares. One, 6, and 12 h after application of the preparation (postprep), nasal swabs were obtained, and S. aureus was enumerated. We observed that treatment of infected PM or human skin explants with SNP resulted in >2.0 log10 CFU reduction in MRSA, regardless of mupirocin sensitivity, which was significantly different from the values for BN- and Bet-treated explants and untreated controls 1 h, 6 h, and 12 h after being washed with PBS plus mucin. Swabbing the anterior nares of human subjects with SNP significantly reduced resident S. aureus compared to saline 1, 6, and 12 h postprep. Finally, pretreatment of PM explants with SNP, followed by a mucin rinse prior to infection, completely prevented MRSA infection. We conclude that SNP may be an attractive alternative for reducing the bioburden of anterior nares prior to surgery.

Indexed as

AnimalsHumansIn Vitro TechniquesMethicillin-Resistant Staphylococcus aureusMupirocinNosePovidone-IodineSkinSwineMupirocinPovidone-Iodine

Identifiers

PMID25733504
PMCPMC4394816
OpenAlexW2163249796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.